bullish
UG Healthcare: Good FY18 Results; Reversion to Industry Average Margins = Potential 200%+ Upside
490 Views25 Aug 2018 17:43
UG Healthcare (UGHC SP) remains severely undervalued after it reported strong full-year 2018 results and has a promising outlook for 2019...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
- UG Healthcare: FY19 Results Show Revenue and Gross Margin Strength; Cost Control Now Needed27 Aug 2019
- UG Healthcare: Weak 2Q19 Driven by One-Off Issue, If 10% NPM Achieved in FY20 Trades at 4x FY20 P/E14 Feb 2019
- AGM UG Healthcare: Better Utilization of Factories to Drive Results Going Forward26 Oct 2018
- UG Healthcare: Good FY18 Results; Reversion to Industry Average Margins = Potential 200%+ Upside25 Aug 2018
- Discover Singapore: UG Healthcare; in Blue-Sky Scenario Trading at Only 3.8x 2020 PE14 May 2018
- UG Healthcare - FY16 Results; Capacity Increase to Continue to Drive Growth25 Aug 2016
x